Tilray slips after Q2 FY25 revenue miss
wildpixel/iStock via Getty Images Tilray Brands (NASDAQ:TLRY) traded ~8% lower in the premarket on Friday
wildpixel/iStock via Getty Images Tilray Brands (NASDAQ:TLRY) traded ~8% lower in the premarket on Friday
Tilray press release (NASDAQ:TLRY): Q2 Non-GAAP EPS of $0.00 beats by $0.01. Revenue of $211M
Tilray (NASDAQ:TLRY) is scheduled to announce Q2 earnings results on Friday, January 10th, before market
Summary: Tilray Brands has expanded its US (Beer / Delta-9 THC) and German operations (Medical
Summary: I am upgrading Tilray Brands from Strong Sell to Neutral due to its massive
A weekly summary of insider trading highlighting notable buying and selling by investors, directors and
Tilray Brands (NASDAQ:TLRY) shares snapped six straight sessions of losses, as the stock rose 1.9%
Amax Photo Tilray (NASDAQ:TLRY) reported positive results from a study of an oral cannabis extract